# A Study to Evaluate Nicotine Uptake and Biomarkers in Smokers Using mybluTM Electronic Cigarettes

> **NCT04430634** · NA · COMPLETED · sponsor: **Fontem US LLC** · enrollment: 40 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **OTHER:** Myblu variant A
- **OTHER:** Myblu variant B
- **OTHER:** Myblu variant C
- **OTHER:** Myblu variant D
- **OTHER:** Myblu variant E
- **OTHER:** Myblu variant F
- **OTHER:** Myblu variant G
- **OTHER:** Myblu variant H

## Key facts

- **NCT ID:** NCT04430634
- **Lead sponsor:** Fontem US LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-01
- **Primary completion:** 2020-01-31
- **Final completion:** 2020-01-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-06-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04430634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04430634, "A Study to Evaluate Nicotine Uptake and Biomarkers in Smokers Using mybluTM Electronic Cigarettes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04430634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*